Srilatha Tangada Selected Research

Hemophilia B (Haemophilia B)

1/2020	Safety, Immunogenicity, and Hemostatic Efficacy of Nonacog Gamma in Patients With Severe or Moderately Severe Hemophilia B: A Continuation Study.
1/2020	Phase 3 Clinical Trial: Perioperative Use of Nonacog Gamma, a Recombinant Factor IX, in Previously Treated Patients With Moderate/Severe Hemophilia B.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Srilatha Tangada Research Topics

Disease

9	Hemophilia A (Haemophilia) 09/2023 - 09/2019
5	Hemorrhage 01/2023 - 09/2019
2	Hemophilia B (Haemophilia B) 01/2020 - 01/2020
1	Headache (Headaches) 09/2019

Drug/Important Bio-Agent (IBA)

6	BAX 855IBA 09/2023 - 09/2019
6	Factor VIII (Coagulation Factor VIII)IBA 01/2023 - 09/2019
3	Hemostatics (Antihemorrhagics)IBA 01/2020 - 09/2019
2	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2020 - 01/2020
2	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 01/2020 - 09/2019
1	CollagenIBA 09/2023
1	Biomarkers (Surrogate Marker)IBA 09/2023
1	gamma-AIBA 01/2020
1	prothrombin complex concentrates (PPSB)IBA 01/2020

Therapy/Procedure

1	Therapeutics 05/2021